FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Gilewski

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Jews

Co-author Network

Publications

TOP 3
Monica Fornier; Teresa A Gilewski; A Abbruzzi; Jacqueline F Bromberg; J Chang; Gabriella D'Andrea-Carlino; Chau Dang; Maura Dickler; S Modi; P G Morris; Larry Norton; Andrew D Seidman; Nancy T Sklarin; Clifford Hudis
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
Maura Dickler; Hope S Rugo; Carey A Eberle; Edi Brogi; James Caravelli; Katherine S Panageas; Jeff Boyd; Benjamin Yeh; Diana E Lake; Chau Dang; Teresa A Gilewski; Jacqueline F Bromberg; Andrew D Seidman; Gabriella D'Andrea-Carlino; Mark M Moasser; Michele Melisko; John W Park; Janet Dancey; Larry Norton; Clifford Hudis
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Chau Dang; Gabriella D'Andrea-Carlino; Diana E Lake; Steve Sugarman; Monica Fornier; Mary Ellen Moynahan; Teresa A Gilewski; Arti Hurria; Nancy Mills; Tiffany Troso-Sandoval; Roshini George; Mark Robson; Maura Dickler; Karen Smith; Katherine S Panageas; Larry Norton; Clifford Hudis
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Gilewski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Monica Fornier; Teresa A Gilewski; A Abbruzzi; Jacqueline F Bromberg; J Chang; Gabriella D'Andrea-Carlino; Chau Dang; Maura Dickler; S Modi; P G Morris; Larry Norton; Andrew D Seidman; Nancy T Sklarin; Clifford Hudis
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(12):2575-81.
2008: Maura Dickler; Hope S Rugo; Carey A Eberle; Edi Brogi; James Caravelli; Katherine S Panageas; Jeff Boyd; Benjamin Yeh; Diana E Lake; Chau Dang; Teresa A Gilewski; Jacqueline F Bromberg; Andrew D Seidman; Gabriella D'Andrea-Carlino; Mark M Moasser; Michele Melisko; John W Park; Janet Dancey; Larry Norton; Clifford Hudis
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7878-83.
2008: Chau Dang; Gabriella D'Andrea-Carlino; Diana E Lake; Steve Sugarman; Monica Fornier; Mary Ellen Moynahan; Teresa A Gilewski; Arti Hurria; Nancy Mills; Tiffany Troso-Sandoval; Roshini George; Mark Robson; Maura Dickler; Karen Smith; Katherine S Panageas; Larry Norton; Clifford Hudis
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.
Clinical breast cancer 2008;8(5):418-24.
2008: Chau Dang; Monica Fornier; Steven Sugarman; Tiffany Troso-Sandoval; Diana E Lake; Gabriella D'Andrea-Carlino; Andrew D Seidman; Nancy T Sklarin; Maura Dickler; Violante E Currie; Teresa A Gilewski; Mary Ellen Moynahan; P Drullinsky; Mark Robson; Carolyn Wasserheit-Leiblich; Nancy Mills; Richard M Steingart; Katherine S Panageas; Larry Norton; Clifford Hudis
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1216-22.
2007: Teresa A Gilewski; Govind Ragupathi; Maura Dickler; Shemeeakah Powell; Sonal Bhuta; Katherine S Panageas; R Rao Koganty; Jeannette Chin-Eng; Clifford Hudis; Larry Norton; Alan N Houghton; Philip O Livingston
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2977-85.
2002: Cristina Musselli; Govind Ragupathi; Teresa A Gilewski; Katherine S Panageas; Yael Spinat; Philip O Livingston
Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1.
International journal of cancer. Journal international du cancer 2002;97(5):660-7.
2001: Teresa A Gilewski
A piece of my mind: the subtle power of compassion.
JAMA : the journal of the American Medical Association 2001;286(24):3052-3.
2001: Monica Fornier; Andrew D Seidman; Maria Theodoulou-Haber; Mary Ellen Moynahan; Violante E Currie; Mark M Moasser; Nancy T Sklarin; Teresa A Gilewski; Gabriella D'Andrea-Carlino; R Salvaggio; Katherine S Panageas; Larry Norton; Clifford Hudis
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3934-41.
2001: Teresa A Gilewski
The art of medicine: teaching oncology fellows about the end of life.
Critical reviews in oncology/hematology 2001;40(2):105-13.
2001: Andrew D Seidman; Monica Fornier; Francisco J Esteva; Lee Tan; S Kaptain; Ariadne M Bach; Katherine S Panageas; Crispinita D Arroyo; V Valero; Violante E Currie; Teresa A Gilewski; Maria Theodoulou-Haber; Mary Ellen Moynahan; Mark M Moasser; Nancy T Sklarin; Maura Dickler; Gabriella D'Andrea-Carlino; M Cristofanilli; E Rivera; Gabriel N Hortobagyi; Larry Norton; Clifford Hudis
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2587-95.
2001: Teresa A Gilewski; Govind Ragupathi; S Bhuta; Linda J Williams; Cristina Musselli; XF Zhang; William G Bornmann; Maria A Spassova; K P Bencsath; Katherine S Panageas; J Chin; Clifford Hudis; Larry Norton; Alan N Houghton; Philip O Livingston; Samuel J Danishefsky
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3270-5.
2000: Richard R Barakat; Teresa A Gilewski; Lois Almadrones; Patricia E Saigo; Venkatraman E Seshan; Clifford Hudis; William J Hoskins
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3459-63.
2000: Teresa A Gilewski; S Adluri; Govind Ragupathi; S Zhang; Tzy-Jyun Yao; Katherine S Panageas; Mary Ellen Moynahan; Alan N Houghton; Larry Norton; Philip O Livingston
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1693-701.
2000: Teresa A Gilewski; Andrew D Seidman; Larry Norton; Clifford Hudis
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel. Breast Cancer Medicine Service.
Cancer chemotherapy and pharmacology 2000;46 Suppl():S23-6.
1999: Clifford Hudis; Monica Fornier; L Riccio; David Lebwohl; John Crown; Teresa A Gilewski; A Surbone; Violante E Currie; Andrew D Seidman; B Reichman; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; Maria Theodoulou-Haber; L Weiselberg; R Salvaggio; Katherine S Panageas; Tzy-Jyun Yao; Larry Norton
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1118.
1999: S Adluri; Teresa A Gilewski; S Zhang; V Ramnath; Govind Ragupathi; Philip O Livingston
Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21.
British journal of cancer 1999;79(11-12):1806-12.
1999: Gabriella D'Andrea-Carlino; DW Fennelly; Larry Norton; José Baselga; Teresa A Gilewski; Clifford Hudis; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; A Surbone; Maria Theodoulou-Haber; M A Templeton; Tzy-Jyun Yao; Andrew D Seidman
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):275-9.
1999: Clifford Hudis; Andrew D Seidman; José Baselga; G Raptis; David Lebwohl; Teresa A Gilewski; Mary Ellen Moynahan; Nancy T Sklarin; DW Fennelly; John Crown; A Surbone; M Uhlenhopp; Elyn Riedel; Tzy-Jyun Yao; Larry Norton
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):93-100.
1998: Mark Robson; Teresa A Gilewski; B Haas; D Levin; Patrick I Borgen; P Rajan; Y Hirschaut; PI Pressman; Paul Peter Rosen; M L Lesser; Larry Norton; Kenneth Offit
BRCA-associated breast cancer in young women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1642-9.
1998: Mark Robson; P Rajan; Paul Peter Rosen; Teresa A Gilewski; Y Hirschaut; PI Pressman; B Haas; Larry Norton; Kenneth Offit
BRCA-associated breast cancer: absence of a characteristic immunophenotype.
Cancer research 1998;58(9):1839-42.
1998: Clifford Hudis; L Riccio; Andrew D Seidman; José Baselga; Violante E Currie; DW Fennelly; Teresa A Gilewski; David Lebwohl; Mary Ellen Moynahan; G Raptis; A Surbone; Nancy T Sklarin; Tzy-Jyun Yao; Deborah Keefe; Larry Norton
Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel.
Cancer investigation 1998;16(2):67-71.
1997: Clifford Hudis; L Riccio; F Holmes; Andrew D Seidman; José Baselga; Violante E Currie; DW Fennelly; Teresa A Gilewski; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; A Surbone; M Uhlenhopp; N Maickel; Tzy-Jyun Yao; S Hellmann; J Usakewicz; Gabriel N Hortobagyi; Larry Norton
Phase II study of semisynthetic paclitaxel in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2198-202.
1997: Mark Robson; MK Dabney; G Rosenthal; S Ludwig; M H Seltzer; Teresa A Gilewski; B Haas; M Osborne; Larry Norton; F Gilbert; Kenneth Offit
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
Genetic testing 1997;1(1):47-51.
1996: Kenneth Offit; Teresa A Gilewski; P McGuire; A Schluger; H Hampel; Karen T Brown; Jeff Swensen; Susan L Neuhausen; M Skolnick; Larry Norton; David E Goldgar
Germline BRCA1 185delAG mutations in Jewish women with breast cancer.
Lancet 1996;347(9016):1643-5.
1996: Andrew D Seidman; Daniel Hochhauser; Marc J Gollub; B Edelman; Tzy-Jyun Yao; Clifford Hudis; P Francis; DW Fennelly; Teresa A Gilewski; Mary Ellen Moynahan; Violante E Currie; José Baselga; William Tong; M O'Donaghue; R Salvaggio; L Auguste; David Spriggs; Larry Norton
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1877-84.
1996: Susan L Neuhausen; Teresa A Gilewski; Larry Norton; T Tran; P McGuire; Jeff Swensen; H Hampel; Patrick I Borgen; Karen T Brown; M Skolnick; D Shattuck-Eidens; Suresh C Jhanwar; David E Goldgar; Kenneth Offit
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Nature genetics 1996;13(1):126-8.
1996: Clifford Hudis; Andrew D Seidman; G Raptis; DW Fennelly; Teresa A Gilewski; José Baselga; Maria Theodoulou-Haber; Nancy T Sklarin; Mary Ellen Moynahan; A Surbone; Violante E Currie; David Lebwohl; M Uhlenhopp; John Crown; Larry Norton
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience.
Seminars in oncology 1996;23(1 Suppl 1):58-64.
1996: Clifford Hudis; Andrew D Seidman; John Crown; Casilda Balmaceda; R Freilich; Teresa A Gilewski; T B Hakes; Violante E Currie; David Lebwohl; José Baselga; G Raptis; Marc J Gollub; M Robles; R Bruno; Larry Norton
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):58-65.
1995: Clifford Hudis; Andrew D Seidman; José Baselga; G Raptis; David Lebwohl; Teresa A Gilewski; Violante E Currie; Mary Ellen Moynahan; Nancy T Sklarin; DW Fennelly
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Seminars in oncology 1995;22(6 Suppl 15):18-23.
1995: Andrew D Seidman; A Tiersten; Clifford Hudis; Marc J Gollub; S Barrett; Tzy-Jyun Yao; J Lepore; Teresa A Gilewski; Violante E Currie; John Crown
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2575-81.
1995: Andrew D Seidman; B S Reichman; John Crown; Tzy-Jyun Yao; Violante E Currie; T B Hakes; Clifford Hudis; Teresa A Gilewski; José Baselga; P Forsythe
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1152-9.
1995: Paul B Jacobsen; Dana H Bovbjerg; M D Schwartz; Clifford Hudis; Teresa A Gilewski; Larry Norton
Conditioned emotional distress in women receiving chemotherapy for breast cancer.
Journal of consulting and clinical psychology 1995;63(1):108-14.
1994: Andrew D Seidman; Larry Norton; B S Reichman; John Crown; Tzy-Jyun Yao; T B Hakes; David Lebwohl; Teresa A Gilewski; Clifford Hudis; A Surbone
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.
Oncology 1994;51 Suppl 1():33-9.
1993: B S Reichman; Andrew D Seidman; John Crown; Robert T Heelan; Tzy-Jyun Yao; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.
Annals of the New York Academy of Sciences 1993;698():398-402.
1993: John Crown; Linda Vahdat; DW Fennelly; P Francis; C Wasserheit; Clifford Hudis; A Kritz; J Schneider; N Hamilton; Teresa A Gilewski
High-intensity chemotherapy with hematopoietic support in breast cancer.
Annals of the New York Academy of Sciences 1993;698():378-88.
1993: Paul B Jacobsen; Dana H Bovbjerg; M D Schwartz; Michael A Andrykowski; A D Futterman; Teresa A Gilewski; Larry Norton; William H Redd
Formation of food aversions in cancer patients receiving repeated infusions of chemotherapy.
Behaviour research and therapy 1993;31(8):739-48.
1993: B S Reichman; Andrew D Seidman; John Crown; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie; Clifford Hudis
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1943-51.
1993: Andrew D Seidman; Larry Norton; B S Reichman; John Crown; Tzy-Jyun Yao; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.
Seminars in oncology 1993;20(4 Suppl 3):40-5.
1993: John Crown; A Kritz; Linda Vahdat; Lilian Reich; Malcolm A S Moore; N Hamilton; J Schneider; M Harrison; Teresa A Gilewski; Clifford Hudis
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1144-9.
1993: John Crown; T Hakes; B Reichman; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie; Tzy-Jyun Yao; Clifford Hudis; Andrew D Seidman
Phase II trial of carboplatin and etoposide in metastatic breast cancer.
Cancer 1993;71(4):1254-7.
1993: Andrew D Seidman; B S Reichman; John Crown; Tzy-Jyun Yao; Robert T Heelan; T B Hakes; David Lebwohl; Teresa A Gilewski; A Surbone; Violante E Currie
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.
Journal of the National Cancer Institute. Monographs 1993;(15):171-5.
1992: Dana H Bovbjerg; William H Redd; Paul B Jacobsen; Sharon Manne; Kathryn L Taylor; A Surbone; John Crown; Larry Norton; Teresa A Gilewski; Clifford Hudis
An experimental analysis of classically conditioned nausea during cancer chemotherapy.
Psychosomatic medicine 1992;54(6):623-37.
1992: Stephanie F Williams; Teresa A Gilewski; R Mick; Jacob Bitran
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1743-7.
1992: J M Richards; Teresa A Gilewski; K Ramming; B Mitchel; L L Doane; Nicholas J Vogelzang
Effective chemotherapy for melanoma after treatment with interleukin-2.
Cancer 1992;69(2):427-9.
1991: J M Richards; Teresa A Gilewski; Nicholas J Vogelzang
Association of interleukin-2 therapy with staphylococcal bacteremia.
Cancer 1991;67(6):1570-5.
1990: A Talerman; Marion S Verp; E Senekjian; Teresa A Gilewski; Nicholas J Vogelzang
True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy.
Cancer 1990;66(12):2668-72.
1990: Teresa A Gilewski; J M Richards
Biologic response modifiers in non-Hodgkin's lymphomas.
Seminars in oncology 1990;17(1):74-87.
1990: Teresa A Gilewski; HM Golomb
Design of combination biotherapy studies: future goals and challenges.
Seminars in oncology 1990;17(1 Suppl 1):3-10; discussion 38-41.
1989: Teresa A Gilewski; Nicholas J Vogelzang
Cost-effectiveness and reimbursement issues in renal cell carcinoma.
Seminars in oncology 1989;16(1 Suppl 1):20-6.
1988: James W Vardiman; Teresa A Gilewski; Mark J Ratain; M A Bitter; B A Bradlow; HM Golomb
Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique.
American journal of clinical pathology 1988;90(3):250-6.